TrialPloS one2011

A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults.

Pablo Tebas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.